Cypherpunk Technologies, Inc. (CYPH)
1.395
-0.32
(-18.90%)
USD |
NASDAQ |
Nov 20, 12:22
Cypherpunk Technologies Cash from Operations (Quarterly) : -2.902M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.902M |
| June 30, 2026 | -2.692M |
| March 31, 2026 | -3.43M |
| December 31, 2025 | -6.619M |
| September 30, 2025 | -8.317M |
| June 30, 2025 | -14.49M |
| March 31, 2025 | -14.48M |
| December 31, 2024 | -15.51M |
| September 30, 2024 | -15.60M |
| June 30, 2024 | -13.67M |
| March 31, 2024 | -15.52M |
| December 31, 2023 | -10.38M |
| September 30, 2023 | -10.49M |
| June 30, 2023 | -10.18M |
| March 31, 2023 | -12.70M |
| December 31, 2022 | -13.01M |
| September 30, 2022 | -12.25M |
| June 30, 2022 | -12.26M |
| March 31, 2022 | -11.52M |
| December 31, 2021 | -10.72M |
| Date | Value |
|---|---|
| September 30, 2021 | -8.102M |
| June 30, 2021 | -7.752M |
| March 31, 2021 | -8.587M |
| December 31, 2020 | -5.988M |
| September 30, 2020 | -6.592M |
| June 30, 2020 | -9.451M |
| March 31, 2020 | -3.926M |
| December 31, 2019 | -5.894M |
| September 30, 2019 | -6.957M |
| June 30, 2019 | -7.183M |
| March 31, 2019 | -6.868M |
| December 31, 2018 | -7.05M |
| September 30, 2018 | -7.452M |
| June 30, 2018 | -6.053M |
| March 31, 2018 | -5.478M |
| December 31, 2017 | -6.369M |
| September 30, 2017 | -2.357M |
| June 30, 2017 | -7.062M |
| March 31, 2017 | -6.349M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Indaptus Therapeutics, Inc. | -1.245M |
| Cue Biopharma, Inc. | -10.08M |
| Yarrow Bioscience, Inc. | -89.96M |
| Faeth Therapeutics, Inc. | -13.00M |
| Pyxis Oncology, Inc. | -16.29M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.00M |
| Cash from Financing (Quarterly) | 57.26M |
| Free Cash Flow | -132.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0327 |
| Free Cash Flow to Equity (Quarterly) | -8.902M |
| Free Cash Flow to Firm (Quarterly) | -8.900M |
| Free Cash Flow Yield | -65.76% |